{"transactions":[{"id":689283,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-12T20:39:55.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":283632,"ownership":{"direct":false,"nature":"By Limited Liability Company"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock). Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 283,632 shares of Class A Common Stock in the Acquisition."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock). Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 283,632 shares of Class A Common Stock in the Acquisition."}],"balance_after":283632,"source":{"system":"sec-edgar","filing":"0001628280-26-056288","document":"wk-form4_1786567192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056288/wk-form4_1786567192.xml","form_type":"4"}},{"id":786871,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:26:47.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032922","document":"wk-form4_1778272004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032922/wk-form4_1778272004.xml","form_type":"4"}},{"id":786870,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:26:47.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032922","document":"wk-form4_1778272004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032922/wk-form4_1778272004.xml","form_type":"4"}},{"id":786869,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:26:47.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":1643963,"source":{"system":"sec-edgar","filing":"0001628280-26-032922","document":"wk-form4_1778272004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032922/wk-form4_1778272004.xml","form_type":"4"}},{"id":968494,"issuer":{"id":4515,"kind":"organization","name":"Spectrum Brands Holdings, Inc."},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T00:08:58.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":4602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2026 if the Reporting Person is a director of the Issuer on such date."}],"balance_after":22141,"source":{"system":"sec-edgar","filing":"0001738054-25-000006","document":"wk-form4_1765930135.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109177/000173805425000006/wk-form4_1765930135.xml","form_type":"4"}},{"id":1106354,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:11:43.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":94906,"price":8.02,"value":761146.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.05 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":1609144,"source":{"system":"sec-edgar","filing":"0001628280-25-032108","document":"wk-form4_1750277496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025032108/wk-form4_1750277496.xml","form_type":"4"}},{"id":1113499,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:19:17.000Z","date":"2025-06-10","kind":"sale","planned":false,"acquired":false,"shares":56426,"price":8.02,"value":452536.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.05 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."}],"balance_after":1704050,"source":{"system":"sec-edgar","filing":"0001628280-25-030958","document":"wk-form4_1749759347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025030958/wk-form4_1749759347.xml","form_type":"4"}},{"id":1155092,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-08T22:17:16.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the\nfirst anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the\nfirst anniversary of the date of grant."}],"balance_after":34819,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-25-023966","document":"wk-form4_1746742630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025023966/wk-form4_1746742630.xml","form_type":"4"}},{"id":1155091,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-08T22:17:16.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":false,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0001628280-25-023966","document":"wk-form4_1746742630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025023966/wk-form4_1746742630.xml","form_type":"4"}},{"id":1155090,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-08T22:17:16.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":true,"shares":40258,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":1760476,"source":{"system":"sec-edgar","filing":"0001628280-25-023966","document":"wk-form4_1746742630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025023966/wk-form4_1746742630.xml","form_type":"4"}},{"id":1157422,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-06T20:29:49.000Z","date":"2025-05-05","kind":"sale","planned":false,"acquired":false,"shares":4900,"price":8,"value":39200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The\nprice included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.01 per share, inclusive. The Reporting Person undertakes to\nprovide Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of\nshares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":1720218,"source":{"system":"sec-edgar","filing":"0001628280-25-022719","document":"wk-form4_1746563381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025022719/wk-form4_1746563381.xml","form_type":"4"}},{"id":1157421,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-06T20:29:49.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":3768,"price":8,"value":30144.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The\nprice included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.01 per share, inclusive. The Reporting Person undertakes to\nprovide Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of\nshares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":1725118,"source":{"system":"sec-edgar","filing":"0001628280-25-022719","document":"wk-form4_1746563381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025022719/wk-form4_1746563381.xml","form_type":"4"}},{"id":1183595,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-04-02T20:12:50.000Z","date":"2025-04-01","kind":"sale","planned":false,"acquired":false,"shares":80000,"price":8.3,"value":664000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative\ndefense conditions of Rule 10b5-1(c). The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.17 to $8.43 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":1728886,"source":{"system":"sec-edgar","filing":"0001628280-25-016184","document":"wk-form4_1743624762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025016184/wk-form4_1743624762.xml","form_type":"4"}},{"id":1222570,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-06T00:12:07.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":80000,"price":8.9,"value":712000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15,2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).  The price included in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.73 to $8.98 per share, inclusive.  The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":1808886,"source":{"system":"sec-edgar","filing":"0001628280-25-010679","document":"wk-form4_1741219921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010679/wk-form4_1741219921.xml","form_type":"4"}},{"id":1281906,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-02-05T21:31:45.000Z","date":"2025-02-03","kind":"sale","planned":false,"acquired":false,"shares":80000,"price":8.14,"value":651200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The\nprice included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.28 per share, inclusive. The Reporting Person undertakes to\nprovide Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of\nshares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":1888886,"source":{"system":"sec-edgar","filing":"0001628280-25-004064","document":"wk-form4_1738791099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025004064/wk-form4_1738791099.xml","form_type":"4"}},{"id":1305230,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-10T21:25:25.000Z","date":"2025-01-08","kind":"sale","planned":true,"acquired":false,"shares":62590,"price":8.01,"value":501345.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).  The price included in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.00 to $8.04 per share, inclusive.  The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":1968886,"source":{"system":"sec-edgar","filing":"0001628280-25-001153","document":"wk-form4_1736544318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025001153/wk-form4_1736544318.xml","form_type":"4"}},{"id":1310772,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-06T21:22:26.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":17410,"price":8.01,"value":139454.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions occurred automatically pursuant to a plan adopted by the Reports Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).  The price included in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.00 to $8.06 per share, inclusive.  The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2031476,"source":{"system":"sec-edgar","filing":"0001628280-25-000581","document":"wk-form4_1736198539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025000581/wk-form4_1736198539.xml","form_type":"4"}},{"id":1357983,"issuer":{"id":4515,"kind":"organization","name":"Spectrum Brands Holdings, Inc."},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T22:51:02.000Z","date":"2024-11-19","kind":"grant","planned":false,"acquired":true,"shares":2770,"price":90.26,"value":250020.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2025 if Reporting Person is a director of the Issuer on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2025 if Reporting Person is a director of the Issuer on such date."}],"balance_after":17539,"source":{"system":"sec-edgar","filing":"0000109177-24-000061","document":"wk-form4_1732143055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109177/000010917724000061/wk-form4_1732143055.xml","form_type":"4"}},{"id":1517588,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-14T20:38:53.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":false,"shares":76453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":76453},"source":{"system":"sec-edgar","filing":"0001628280-24-023241","document":"wk-form4_1715719116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024023241/wk-form4_1715719116.xml","form_type":"4"}},{"id":1517587,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-14T20:38:53.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":true,"shares":76453,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":2048886,"source":{"system":"sec-edgar","filing":"0001628280-24-023241","document":"wk-form4_1715719116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024023241/wk-form4_1715719116.xml","form_type":"4"}},{"id":1526381,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-06T21:35:55.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":40258,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0001628280-24-020741","document":"wk-form4_1715031344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024020741/wk-form4_1715031344.xml","form_type":"4"}},{"id":1692670,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-01-03T21:36:04.000Z","date":"2024-01-01","kind":"gift","planned":false,"acquired":true,"shares":1598115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person is a beneficiary of one of the Trusts.  Following the execution of the transactions described in the preceding footnote, on January 1, 2024, the reporting person received a distribution from such Trust of 1,598,115 shares of the Class A Common Stock of the issuer."}],"balance_after":1972433,"source":{"system":"sec-edgar","filing":"0000898432-24-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089843224000011/form4.xml","form_type":"4"}},{"id":1692669,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-01-03T21:36:04.000Z","date":"2024-01-01","kind":"other","planned":false,"acquired":false,"shares":33458067,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person previously controlled an entity (the \"Trustee\") that serves as the sole trustee of certain trusts (the \"Trusts\") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer.  On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee.  In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024.  As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person previously controlled an entity (the \"Trustee\") that serves as the sole trustee of certain trusts (the \"Trusts\") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer.  On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee.  In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024.  As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee."}],"balance_after":374318,"source":{"system":"sec-edgar","filing":"0000898432-24-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089843224000011/form4.xml","form_type":"4"}},{"id":1725541,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2023-12-01T21:15:17.000Z","date":"2021-12-01","kind":"other","planned":false,"acquired":true,"shares":3073298,"ownership":{"direct":false,"nature":"Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 1, 2021, an entity controlled by the reporting person was designated as the trustee of a trust that holds 3,073,298 shares of the Class A Common Stock of the issuer.  These shares were not previously reported as being beneficially owned by the reporting person due to a clerical error.  The reporting person is filing this amendment to the Form 4 filed on December 20, 2021, to include the shares held by the trust in the number of shares reported as being beneficially owned by the reporting person through trusts which the reporting person may be deemed to control.  As a result of the error, all Section 16 reports filed by the reporting person after December 20, 2021 understated the number of shares of the Class A Common stock of the issuer beneficially owned by the reporting person by 3,073,298 shares.  All such subsequent reports are hereby updated by this amendment."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 1, 2021, an entity controlled by the reporting person was designated as the trustee of a trust that holds 3,073,298 shares of the Class A Common Stock of the issuer.  These shares were not previously reported as being beneficially owned by the reporting person due to a clerical error.  The reporting person is filing this amendment to the Form 4 filed on December 20, 2021, to include the shares held by the trust in the number of shares reported as being beneficially owned by the reporting person through trusts which the reporting person may be deemed to control.  As a result of the error, all Section 16 reports filed by the reporting person after December 20, 2021 understated the number of shares of the Class A Common stock of the issuer beneficially owned by the reporting person by 3,073,298 shares.  All such subsequent reports are hereby updated by this amendment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 1, 2021, an entity controlled by the reporting person was designated as the trustee of a trust that holds 3,073,298 shares of the Class A Common Stock of the issuer.  These shares were not previously reported as being beneficially owned by the reporting person due to a clerical error.  The reporting person is filing this amendment to the Form 4 filed on December 20, 2021, to include the shares held by the trust in the number of shares reported as being beneficially owned by the reporting person through trusts which the reporting person may be deemed to control.  As a result of the error, all Section 16 reports filed by the reporting person after December 20, 2021 understated the number of shares of the Class A Common stock of the issuer beneficially owned by the reporting person by 3,073,298 shares.  All such subsequent reports are hereby updated by this amendment."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":15960731,"source":{"system":"sec-edgar","filing":"0000898432-23-000827","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089843223000827/form4.xml","form_type":"4/A","original_submission_date":"2021-12-01"}},{"id":1729213,"issuer":{"id":4515,"kind":"organization","name":"Spectrum Brands Holdings, Inc."},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-28T21:19:31.000Z","date":"2023-11-24","kind":"grant","planned":false,"acquired":true,"shares":3775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2024 if Reporting Person is a director of the Issuer on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2024 if Reporting Person is a director of the Issuer on such date."}],"balance_after":14769,"source":{"system":"sec-edgar","filing":"0000109177-23-000058","document":"wk-form4_1701206355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109177/000010917723000058/wk-form4_1701206355.xml","form_type":"4"}},{"id":1746807,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock and Common Units","published_at":"2023-11-08T23:21:49.000Z","date":"2023-11-07","kind":"other","planned":false,"acquired":false,"shares":17497336,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The Issuer of the Common Units is Amneal Pharmaceuticals, LLC."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":17497336},"source":{"system":"sec-edgar","filing":"0001209191-23-054741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123054741/doc4.xml","form_type":"4"}},{"id":1746806,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-11-08T23:21:49.000Z","date":"2023-11-07","kind":"other","planned":false,"acquired":true,"shares":17497336,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the \"Issuer\") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) (\"Old PubCo\") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC (\"AP\"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":30384769,"source":{"system":"sec-edgar","filing":"0001209191-23-054741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123054741/doc4.xml","form_type":"4"}},{"id":1896763,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-11T20:15:21.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":80128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80128},"source":{"system":"sec-edgar","filing":"0001209191-23-028733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028733/doc4.xml","form_type":"4"}},{"id":1896762,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-11T20:15:21.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":76453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":76453,"derivative":{"underlying":"Class A Common Stock","underlying_shares":76453},"source":{"system":"sec-edgar","filing":"0001209191-23-028733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028733/doc4.xml","form_type":"4"}},{"id":1896761,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-11T20:15:21.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":80128,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":374318,"source":{"system":"sec-edgar","filing":"0001209191-23-028733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028733/doc4.xml","form_type":"4"}},{"id":2103023,"issuer":{"id":4515,"kind":"organization","name":"Spectrum Brands Holdings, Inc."},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T21:53:05.000Z","date":"2022-11-25","kind":"grant","acquired":true,"shares":5020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2023 if Reporting Person is a director of the Issuer on such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2023 if Reporting Person is a director of the Issuer on such date."}],"balance_after":10994,"source":{"system":"sec-edgar","filing":"0000109177-22-000046","document":"wf-form4_166975876860565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109177/000010917722000046/wf-form4_166975876860565.xml","form_type":"4"}},{"id":2276259,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-10T23:04:07.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":80128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":80128,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80128},"source":{"system":"sec-edgar","filing":"0001209191-22-028166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028166/doc4.xml","form_type":"4"}},{"id":2276258,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-10T23:04:07.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":35406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35406},"source":{"system":"sec-edgar","filing":"0001209191-22-028166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028166/doc4.xml","form_type":"4"}},{"id":2276257,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-05-10T23:04:07.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":35406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":294190,"source":{"system":"sec-edgar","filing":"0001209191-22-028166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028166/doc4.xml","form_type":"4"}},{"id":2463956,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-20T23:49:19.000Z","date":"2021-12-17","kind":"purchase","acquired":true,"shares":50000,"price":4.21,"value":210500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.14 to $4.35. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or of the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":258784,"source":{"system":"sec-edgar","filing":"0001209191-21-070646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121070646/doc4.xml","form_type":"4"}},{"id":2469002,"issuer":{"id":4515,"kind":"organization","name":"Spectrum Brands Holdings, Inc."},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-17T22:20:19.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":2441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2022 if the Reporting Person is a director of the Issuer on such date."}],"balance_after":5974,"source":{"system":"sec-edgar","filing":"0000109177-21-000101","document":"wf-form4_163977959973266.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109177/000010917721000101/wf-form4_163977959973266.xml","form_type":"4"}},{"id":2723253,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T18:09:15.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":46218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46218},"source":{"system":"sec-edgar","filing":"0001209191-21-030813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030813/doc4.xml","form_type":"4"}},{"id":2723252,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T18:09:15.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":35406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":35406,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35406},"source":{"system":"sec-edgar","filing":"0001209191-21-030813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030813/doc4.xml","form_type":"4"}},{"id":2723251,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-07T18:09:15.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":46218,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":208784,"source":{"system":"sec-edgar","filing":"0001209191-21-030813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030813/doc4.xml","form_type":"4"}},{"id":2933885,"issuer":{"id":4515,"kind":"organization","name":"Spectrum Brands Holdings, Inc."},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-23T21:40:21.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":3533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person was awarded restricted stock units under the Company's 2011 Omnibus Equity Award Plan which are settled in shares of common stock of the Issuer and which are scheduled to vest on October 1, 2021 if Reporting Person is a director of the Issuer on such date."}],"balance_after":3533,"source":{"system":"sec-edgar","filing":"0000109177-20-000064","document":"wf-form4_160875944818333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109177/000010917720000064/wf-form4_160875944818333.xml","form_type":"4"}},{"id":3158173,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-07T21:23:44.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000899243-20-012259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/doc4.xml","form_type":"4"}},{"id":3158172,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-07T21:23:44.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":46218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":46218,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46218},"source":{"system":"sec-edgar","filing":"0000899243-20-012259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/doc4.xml","form_type":"4"}},{"id":3158171,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-05-07T21:23:44.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":6459,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":162566,"source":{"system":"sec-edgar","filing":"0000899243-20-012259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/doc4.xml","form_type":"4"}},{"id":3217972,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-03-11T01:14:39.000Z","date":"2020-03-03","kind":"purchase","acquired":true,"shares":117889,"price":3.94,"value":464482.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.86 to $4.00, inclusive."}],"balance_after":156107,"source":{"system":"sec-edgar","filing":"0000899243-20-007820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/doc4.xml","form_type":"4"}},{"id":3217971,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-03-11T01:14:39.000Z","date":"2020-03-02","kind":"purchase","acquired":true,"shares":32111,"price":3.88,"value":124590.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.84 to $3.90, inclusive."}],"balance_after":38218,"source":{"system":"sec-edgar","filing":"0000899243-20-007820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/doc4.xml","form_type":"4"}},{"id":3374712,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Units","published_at":"2019-11-12T21:47:42.000Z","date":"2019-11-11","kind":"exercise","acquired":false,"shares":12887433,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By trusts which the reporting person may be deemed to control.  The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":17497336,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12887433},"source":{"system":"sec-edgar","filing":"0001628280-19-013997","document":"wf-form4_157359524653914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828019013997/wf-form4_157359524653914.xml","form_type":"4"}},{"id":3374711,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2019-11-12T21:47:42.000Z","date":"2019-11-11","kind":"other","acquired":false,"shares":12887433,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the cancellation for no consideration of Class B Common Stock in connection with the conversion of the Common Units into shares of Class A Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By trusts which the reporting person may be deemed to control.  The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":17497336,"source":{"system":"sec-edgar","filing":"0001628280-19-013997","document":"wf-form4_157359524653914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828019013997/wf-form4_157359524653914.xml","form_type":"4"}},{"id":3374710,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-11-12T21:47:42.000Z","date":"2019-11-11","kind":"exercise","acquired":true,"shares":12887433,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By trusts which the reporting person may be deemed to control.  The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":12887433,"source":{"system":"sec-edgar","filing":"0001628280-19-013997","document":"wf-form4_157359524653914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828019013997/wf-form4_157359524653914.xml","form_type":"4"}},{"id":3535257,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:49:39.000Z","date":"2019-05-08","kind":"exercise","acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001723128-19-000073","document":"wf-form4_155735216396679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/wf-form4_155735216396679.xml","form_type":"4"}},{"id":3535256,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:49:39.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  The restricted stock units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  The restricted stock units do not expire."}],"balance_after":6459,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0001723128-19-000073","document":"wf-form4_155735216396679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/wf-form4_155735216396679.xml","form_type":"4"}},{"id":3535255,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2019-05-08T21:49:39.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":28044,"derivative":{"exercise_price":14.05,"expiration_date":"2029-05-06","underlying":"Class A Common Stock","underlying_shares":28044},"source":{"system":"sec-edgar","filing":"0001723128-19-000073","document":"wf-form4_155735216396679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/wf-form4_155735216396679.xml","form_type":"4"}},{"id":3535254,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-08T21:49:39.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":6107,"source":{"system":"sec-edgar","filing":"0001723128-19-000073","document":"wf-form4_155735216396679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/wf-form4_155735216396679.xml","form_type":"4"}},{"id":3871201,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Units","published_at":"2018-07-09T21:15:27.000Z","date":"2018-07-05","kind":"other","acquired":true,"shares":30384769,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution of Class B Common Stock and Common Units from APHC Holdings, LLC to its members for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By trusts which the reporting person may be deemed to control.  The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":30384769,"derivative":{"underlying":"Common Units","underlying_shares":30384769},"source":{"system":"sec-edgar","filing":"0000899243-18-019667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318019667/doc4.xml","form_type":"4"}},{"id":3871200,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2018-07-09T21:15:27.000Z","date":"2018-07-05","kind":"other","acquired":true,"shares":30384769,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution of Class B Common Stock and Common Units from APHC Holdings, LLC to its members for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By trusts which the reporting person may be deemed to control.  The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":30384769,"source":{"system":"sec-edgar","filing":"0000899243-18-019667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318019667/doc4.xml","form_type":"4"}},{"id":3941188,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-09T22:36:51.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."}],"balance_after":6107,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0000899243-18-012160","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318012160/doc4.xml","form_type":"4"}},{"id":3941187,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-09T22:36:51.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":24977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on May 07, 2019."}],"balance_after":24977,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":24977},"source":{"system":"sec-edgar","filing":"0000899243-18-012160","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318012160/doc4.xml","form_type":"4"}}]}